
Lorundrostat
CAS No. 1820940-17-7
Lorundrostat( —— )
Catalog No. M35665 CAS No. 1820940-17-7
Lorundrostat (MT-4129) is an aldosterone synthase inhibitor with antihypertensive activity that lowers systolic blood pressure.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 178 | Get Quote |
![]() ![]() |
5MG | 275 | Get Quote |
![]() ![]() |
10MG | 432 | Get Quote |
![]() ![]() |
25MG | 821 | Get Quote |
![]() ![]() |
50MG | 1122 | Get Quote |
![]() ![]() |
100MG | 1485 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLorundrostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionLorundrostat (MT-4129) is an aldosterone synthase inhibitor with antihypertensive activity that lowers systolic blood pressure.
-
DescriptionLorundrostat (MT-4129) is an orally activealdosterone synthaseinhibitor. Lorundrostat can be used in studies of high blood pressure.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1820940-17-7
-
Formula Weight451.56
-
Molecular FormulaC24H33N7O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (73.81 mM; Ultrasonic; (HCL ,pH≈2); )
-
SMILESCC(=O)N[C@H]1CC[C@@H](CC1)NC(=O)CN1CCN(CC1)c1nncc(n1)-c1ccc(C)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
molnova catalog



related products
-
Dimiracetam
Dimiracetam (NT-11624) is an orally active anti-neuropathy compound that inhibits hypersensitivity and neurological alterations and may be used in the study of cognitive disorders, depression and neuropathic pain.
-
DiosMetin 7-O-β-D-Gl...
DiosMetin 7-O-β-D-Glucuronide is an antioxidant constituent in the fruits of Luffa cylindrical.
-
ACTB-1003
ACTB-1003 is an oral kinase inhibitor (IC50: 6/2/4 nM, for FGFR1/VEGFR2/Tie-2).